Electra Therapeutics Inc. (ETRA)
$7.35-7.78%Close
Snapshot
- 1 week
- -14.9%-10.2% vs SPY
- 1 month
- -24.5%-19.1% vs SPY
- Market cap
- $155.9M
- Days to cover
- 1.0
- Short change
- -41.7%
- Price target
- $31.00+321.8% upside
Signal: Call, Regime, Alignment, Score, ATR trend, HiLo flip, Coil, Exhaustion, Topping · Technicals (EMA stack, slope, squeeze, stochastic, MACD-Z, DI+) · Price & returns: 3 months, Year to date, 1 year
Price & returns: 3 years, 5 years
Signal: Composite · Performance (Q-Score, Sharpe, Sortino, Calmar, CAGR, drawdown, alpha)
Signal evidence
Best Combo (today's action, held-out profit factor and family votes) · White Arrow (the call, its profit factor and closed trades) · Regime (today's regime and the regime model's profit factor) · Exhaustion (whether buyers or sellers are stretched today and the latest release)
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company
About
Electra Therapeutics Inc. (ETRA). Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Profile
SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeNASDAQ
CountryUS
CEOQuehuong Dong
IPOSep 18, 2026
Employees46
Shares outstanding21.2M
Float-
Free float-
Websiteelectra-therapeutics.com
Key executives
- Quehuong DongPresident, CEO & DirectorUSD 735K
- Kim-Hien DaoChief Medical OfficerUSD 547K
- Gary S. KoeChief Technology OfficerUSD 523K
- Graham ParryChief Scientific Officer
Snapshot
Price & returns1 month -24.5%
- 1 week
- -14.9%-10.2% vs SPY
- 1 month
- -24.5%-19.1% vs SPY
Valuationmarket cap $155.9M
- Market cap
- $155.9M
Short interest & optionsDays to cover 1.0 · Short change -41.7%
- Days to cover
- 1.0
- Short change
- -41.7%
Street & earningsTarget $31.00 (+321.8% upside)
- Price target
- $31.00+321.8% upside
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company
About
Electra Therapeutics Inc. (ETRA). Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Profile
SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeNASDAQ
CountryUS
CEOQuehuong Dong
IPOSep 18, 2026
Employees46
Shares outstanding21.2M
Float-
Free float-
Websiteelectra-therapeutics.com
Key executives
- Quehuong DongPresident, CEO & DirectorUSD 735K
- Kim-Hien DaoChief Medical OfficerUSD 547K
- Gary S. KoeChief Technology OfficerUSD 523K
- Graham ParryChief Scientific Officer
Fundamentals
SCORES & PROFILE
FUND, Value, Growth and GARP scores and the archetype
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-
---
VALUATION
P/E TTM-
P/E FWD-
SECTOR PE20.57
INDUSTRY PE50.42
P/B-
P/FCF-
EV/EBITDA-
EV/EBIT-
FCF YIELD-
TRUE FCF YLD-
PEG-
Risk
INT COV-
D/E-
ALTMAN Z-
CURR RATIO-
ND/EBITDA-
Fundamentals
Scores & profile
FUND, Value, Growth and GARP scores and the archetype
ROIC-
Revenue YoY-
ROE-
EPS YoY-
ROA-
---
Valuation
P/E (TTM)-
P/E (forward)-
Sector P/E20.57
Industry P/E50.42
P/B-
P/FCF-
EV/EBITDA-
EV/EBIT-
FCF yield-
True FCF yield-
PEG-
Risk
Interest cover-
Debt/equity-
Altman Z-
Current ratio-
Net debt/EBITDA-
